William Ho
Net worth: 182 852 $ as of 2026-06-29
Net worth: 182 852 $ as of 2026-06-29
William T.
Ho is the founder of IN8bio, Inc., founded in 2015, serving as Chief Executive Officer & Director since 2026.
Mr. Ho was the founder of AlephPoint Capital Management LP, founded in 2014, and served as Managing Partner from 2014 to 2017.
Mr. Ho is currently President & Chief Executive Officer at Incysus Ltd. Former positions include Senior Financial Analyst at CuraGen Corp., Principal at SG Cowen Asset Management, Associate at Piper Sandler & Co. (Broker) from 2003 to 2006, Principal at NEX International Ltd. in 2010, Associate at Cowen & Co. LLC from 2001 to 2002, Senior Research Analyst at Banc of America Securities LLC from 2006 to 2008, and Consultant at New Leaf Venture Partners LLC.
Education includes an MBA from the University of Notre Dame and an undergraduate degree from McMaster University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IN8BIO, INC. 1.32% | 2026-05-08 | 129,682 ( 1.32% ) | 182 852 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| IN8BIO, INC. | Founder | 2015-10-31 |
Incysus Ltd.
Incysus Ltd. BiotechnologyHealth Technology Develops shelf cellular therapy for the treatment of solid tumor cancers | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
AlephPoint Capital Management LP
AlephPoint Capital Management LP Investment Trusts/Mutual FundsMiscellaneous AlephPoint Capital Management LP is a company located in the US and has subsidiaries in the United States. | Founder | 2016-12-31 |
| ICAP PLC | Corporate Officer/Principal | 2010-12-29 |
Banc of America Securities LLC
Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2008-12-30 |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2006-06-29 |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Corporate Officer/Principal | 2003-06-29 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
SG Cowen Asset Management
SG Cowen Asset Management Investment ManagersFinance Provides investment advice | Finance |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NEX International Ltd.
NEX International Ltd. Investment Banks/BrokersFinance Provides electronic brokerage services | Finance |
Banc of America Securities LLC
Banc of America Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Leaf Venture Partners LLC
New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
AlephPoint Capital Management LP
AlephPoint Capital Management LP Investment Trusts/Mutual FundsMiscellaneous AlephPoint Capital Management LP is a company located in the US and has subsidiaries in the United States. | Miscellaneous |
Incysus Ltd.
Incysus Ltd. BiotechnologyHealth Technology Develops shelf cellular therapy for the treatment of solid tumor cancers | Health Technology |
IN8bio, Inc.
IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions